CSIMarket
 


Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

DGX's EPS from Cont. Operations Growth by Quarter and Year

Quest Diagnostics Inc's EPS from Cont. Operations results by quarter and year




DGX EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 1.72 0.88 3.18 4.26
III Quarter September 1.99 2.20 4.11 4.20
II Quarter June 2.08 2.00 5.05 1.38
I Quarter March 1.80 2.97 3.52 0.74
FY   7.59 8.05 15.86 10.58



DGX EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Comment
Quest Diagnostics Inc reported EPS from Cont. Operations surge of 95.45% year on year in the fourth quarter 2023, to $ 1.72 , this is lower than Quest Diagnostics Inc's recent average EPS from Cont. Operations surge of 313.78%.

Looking into fourth quarter 2023 results within Medical Laboratories industry 6 other companies have achieved higher EPS from Cont. Operations growth. While Quest Diagnostics Inc' s EPS from Cont. Operations jump of 95.45% ranks overall at the positon no. 884 in the fourth quarter 2023.




DGX EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 95.45 % -72.33 % -25.35 % 127.81 %
III Quarter September -9.55 % -46.47 % -2.14 % 164.15 %
II Quarter June 4 % -60.4 % 265.94 % -9.21 %
I Quarter March -39.39 % -15.63 % 375.68 % -39.34 %
FY   -5.71 % -49.24 % 49.91 % 70.65 %

Financial Statements
Quest Diagnostics Inc's fourth quarter 2023 EPS from Cont. Operations $ 1.72 DGX's Income Statement
Quest Diagnostics Inc's fourth quarter 2022 EPS from Cont. Operations $ 0.88 Quarterly DGX's Income Statement
New: More DGX's historic EPS from Cont. Operations Growth >>


DGX EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -13.57 % -60 % -22.63 % 1.43 %
III Quarter September -4.33 % 10 % -18.61 % 204.35 %
II Quarter June 15.56 % -32.66 % 43.47 % 86.49 %
I Quarter March 104.55 % -6.6 % -17.37 % -60.43 %
FY (Year on Year)   -5.71 % -49.24 % 49.91 % 70.65 %




EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #62
Overall #884

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
6023.83 % 313.78 % -97.82 %
(March 31, 2009)   (Dec. 31, 2010)
EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #62
Overall #884
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
6023.83 % 313.78 % -97.82 %
(March 31, 2009)   (Dec. 31, 2010)

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Quest Diagnostics Inc's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
18888.64 % 265.03 % -99.4 %
(March 31, 2009)  


DGX's IV. Quarter Q/Q EPS from Cont. Operations Comment
In the IV. Quarter 2023 Quest Diagnostics Inc realized drop in EPS from Cont. Operations from the third quarter by -13.57% to $ 1.72 , from $ 1.99 achived in the previous quarter.

It's not important problem, as Quest Diagnostics Inc's EPS from Cont. Operations generally seem to dip in this quarter Xavier B. Collins, Medical Laboratories industry veteran from San Francisco noted.

Within Medical Laboratories industry 7 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Quest Diagnostics Inc's EPS from Cont. Operations growth quarter on quarter, overall rank is 781.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #63
Overall #781
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #63
Overall #781
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
18888.64 % 265.03 % -99.4 %
(March 31, 2009)  


DGX's IV. Quarter Q/Q EPS from Cont. Operations Comment
In the IV. Quarter 2023 Quest Diagnostics Inc realized drop in EPS from Cont. Operations from the third quarter by -13.57% to $ 1.72 , from $ 1.99 released in the previous quarter.

But that's not important issue, as IV. Quarter EPS from Cont. Operations always seem to dip in the IV. Quarter Xavier B. Collins, Medical Laboratories industry veteran from San Francisco noted.

Within Medical Laboratories industry 7 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Quest Diagnostics Inc's EPS from Cont. Operations growth quarter on quarter, overall rank is 781.


Quest Diagnostics Inc's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ 7.59 $ 6.75 $ 6.96 $ 6.88 $ 8.05
Y / Y EPS from Cont. Operations Growth (TTM) -5.68 % -34.84 % -43.27 % -55.09 % -49.28 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 1083 # 145 # 1472 # 686 # 304
Seqeuential EPS from Cont. Operations Change (TTM) 12.49 % -3.02 % 1.16 % -14.54 % -22.28 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 884 # 123 # 1361 # 993 # 918




Cumulative EPS from Cont. Operations growth Comment
Quest Diagnostics Inc showed decline, but improvement compare to trailing twelve month EPS from Cont. Operations decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Quest Diagnostics Inc's annual EPS from Cont. Operations fall would be -5.68% year on year to $8 .

In the Healthcare sector 67 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 145 to 1083.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
6023.83 %
313.78 %
-97.82 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 68
Overall # 1083

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
6023.83 %
313.78 %
-97.82 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 62
S&P 500 # 884
Cumulative EPS from Cont. Operations growth Comment
Quest Diagnostics Inc showed decline, but improvement compare to trailing twelve month EPS from Cont. Operations decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Quest Diagnostics Inc's annual EPS from Cont. Operations drop would be -5.68% year on year to $8 .

In the Healthcare sector 67 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 145 to 1083.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
6023.83 %
313.78 %
-97.82 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 68
Overall # 1083

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
6023.83 %
313.78 %
-97.82 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 62
S&P 500 # 884




Other EPS from Cont. Operations Growth
Medical Laboratories Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
DGX's EPS from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for DGX's Competitors
EPS from Cont. Operations Growth for Quest Diagnostics Inc's Suppliers
EPS from Cont. Operations Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Comparisons



Companies with similar EPS from Cont. Operations drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2023
Tenet Healthcare Corp147.66%$ 147.658 
Davita Inc 120.38%$ 120.379 
Vericel Corporation117.03%$ 117.031 
Iqvia Holdings Inc 110.58%$ 110.579 
Stryker Corp102.31%$ 102.306 
Alpha Pro Tech Ltd 102.01%$ 102.011 
Corcept Therapeutics Inc98.20%$ 98.198 
Quest Diagnostics Inc96.11%$ 96.115 
Intuitive Surgical Inc 86.05%$ 86.050 
Astrazeneca Plc81.13%$ 81.132 
Dr Reddy s Laboratories Limited76.47%$ 76.471 
3m Company72.40%$ 72.405 
Electromed Inc 66.67%$ 66.667 
Select Medical Holdings Corp65.65%$ 65.648 
Neurocrine Biosciences Inc 63.08%$ 63.082 
United Therapeutics Corporation60.16%$ 60.158 
Cytek Biosciences Inc 57.66%$ 57.659 
Abbott Laboratories55.26%$ 55.256 
Halozyme Therapeutics Inc 55.17%$ 55.172 
Tactile Systems Technology Inc 52.10%$ 52.101 
Lemaitre Vascular Inc 48.69%$ 48.693 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com